| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 0.955 | 89 | 0 | 2014 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.100 | None | 0.897 | 58 | 0 | 1995 | 2020 | |||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.969 | 57 | 0 | 1997 | 2019 | ||||||||
|
transcription termination factor 1 | 0.537 | 0.500 | 6.2E-13 |
|
group | 0.100 | None | 0.935 | 46 | 0 | 1997 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.400 | None | 0.980 | 44 | 0 | 1995 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 39 | 0 | 2002 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 36 | 0 | 1996 | 2019 | ||||||||
|
caudal type homeobox 2 | 0.458 | 0.769 | 0.53 |
|
group | 0.100 | None | 0.953 | 34 | 0 | 2001 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.100 | None | 0.971 | 34 | 0 | 1992 | 2019 | ||||||||
|
EMAP like 4 | 0.569 | 0.577 | 4.8E-04 |
|
group | 0.100 | None | 1.000 | 33 | 0 | 2008 | 2018 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.100 | None | 0.971 | 33 | 0 | 1983 | 2018 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
group | 0.100 | None | 0.970 | 33 | 0 | 1998 | 2014 | |||||||||
|
ROS proto-oncogene 1, receptor tyrosine kinase | 0.439 | 0.885 | 1.6E-72 |
|
group | 0.100 | None | 1.000 | 33 | 0 | 2012 | 2019 | ||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
group | 0.100 | None | 0.968 | 31 | 0 | 1998 | 2014 | |||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 1.000 | 28 | 0 | 1990 | 2019 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
group | 0.400 | None | 0.966 | 27 | 0 | 1986 | 2018 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
group | 0.400 | None | 0.962 | 24 | 0 | 2001 | 2018 | ||||||||
|
mucin 5AC, oligomeric mucus/gel-forming | 0.483 | 0.808 | 1.0E-08 |
|
group | 0.100 | None | 1.000 | 23 | 0 | 1993 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 23 | 0 | 1988 | 2018 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
group | 0.400 | None | 0.962 | 22 | 0 | 1998 | 2019 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
group | 0.100 | None | 0.917 | 22 | 0 | 1992 | 2017 | ||||||||
|
cytoskeleton associated protein 4 | 0.436 | 0.731 | 0.51 |
|
group | 0.100 | None | 0.952 | 21 | 0 | 2001 | 2019 | ||||||||
|
mucin 2, oligomeric mucus/gel-forming | 0.486 | 0.808 | 9.4E-10 |
|
group | 0.400 | None | 1.000 | 21 | 0 | 1994 | 2019 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
group | 0.400 | None | 0.870 | 21 | 0 | 1993 | 2020 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.917 | 21 | 0 | 2001 | 2020 |